Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Angiogenesis as a potential treatment strategy for rheumatoid arthritis
Yan Wang, Hong Wu, Ran Deng
European Journal of Pharmacology (2021) Vol. 910, pp. 174500-174500
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Pathological angiogenesis: mechanisms and therapeutic strategies
Andrew C. Dudley, Arjan W. Griffioen
Angiogenesis (2023) Vol. 26, Iss. 3, pp. 313-347
Open Access | Times Cited: 199
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Qian Ding, Wei Hu, Ran Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 191
Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs
Weiyao Jing, Cui Liu, Su Chenghong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 55
Chemokines and chemokine receptors as promising targets in rheumatoid arthritis
Masanori A. Murayama, Jun Shimizu, Chie Miyabe, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 41
Unveiling the Anti-Angiogenic Potential of Small-Molecule (Kinase) Inhibitors for Application in Rheumatoid Arthritis
Fatemeh Khodadust, Eva M. L. Philippon, Maarten M. Steinz, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 102-102
Open Access | Times Cited: 1
Ferroptosis in inflammatory arthritis: A promising future
Siyuan Chang, Mengshi Tang, Bikui Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Recent advances in nano-targeting drug delivery systems for rheumatoid arthritis treatment
Hanmei Li, Rui Gou, Jiaying Liao, et al.
Acta Materia Medica (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 30
Role of the CXCR6/CXCL16 axis in autoimmune diseases
Nandi Bao, Bo Fu, Xiaoling Zhong, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110530-110530
Closed Access | Times Cited: 22
Cytokines, Vascular Endothelial Growth Factors, and PlGF in Autoimmunity: Insights From Rheumatoid Arthritis to Multiple Sclerosis
Young eun Lee, Seung‐Hyo Lee, Wan‐Uk Kim
Immune Network (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Geniposide alleviates VEGF-induced angiogenesis by inhibiting VEGFR2/PKC/ERK1/2-mediated SphK1 translocation
Yan Wang, Hong Wu, Binjie Gui, et al.
Phytomedicine (2022) Vol. 100, pp. 154068-154068
Closed Access | Times Cited: 33
The Role of Semaphorins in the Pathogenesis of Rheumatoid Arthritis
Jakub Rosik, Joanna Kulpa, Marcin Szczepanik, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 618-618
Open Access | Times Cited: 5
Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges
Shujing Ren, Yuhang Xu, Xingpeng Dong, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
A COMPLETE SOJOURN ON NANOTECHNOLOGICAL ADVANCEMENTS AND NANOCARRIERS APPLICATIONS IN ARTHRITIS MANAGEMENT
Ashwani Kumar, Rashmi Maurya, Preeti Patel, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106705-106705
Closed Access
Perspectives of Exosomal ncRNAs in the Treatment of Bone Metabolic Diseases: Focusing on Osteoporosis, Osteoarthritis, and Rheumatoid Arthritis
Daodi Qiu, Binghan Yan, Haipeng Xue, et al.
Experimental Cell Research (2025), pp. 114457-114457
Closed Access
Inflammatory and angiogenic serum profile of refractory rheumatoid arthritis
M. Lesturgie-Talarek, Virginie Gonzalez, Alice Combier, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Qing-Luo-Yin Eases T Cells-Mediated Angiogenesis in Adjuvant-Induced Arthritis Rats by Activating PPARγ
Meng-Ke Song, Meng-Qi Wang, Yunjun Ruan, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3469-3484
Open Access
Elucidating the role of hypoxia-inducible factor in rheumatoid arthritis
Essa M. Sabi, Anuja Singh, Ziyad M. Althafar, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 737-748
Closed Access | Times Cited: 25
Potential Anti-Rheumatoid Arthritis Activities and Mechanisms of Ganoderma lucidum Polysaccharides
Meng Meng, Jialin Yao, Yukun Zhang, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2483-2483
Open Access | Times Cited: 13
Resveratrol-induced SIRT1 activation inhibits glycolysis-fueled angiogenesis under rheumatoid arthritis conditions independent of HIF-1α
Tiantian Jiang, Cong‐Lan Ji, Li‐Jun Yu, et al.
Inflammation Research (2023) Vol. 72, Iss. 5, pp. 1021-1035
Closed Access | Times Cited: 13
Role of miRNAs in Rheumatoid Arthritis Therapy
Yiping Zhang, Mei-wen Yang, Hongyan Xie, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1749-1749
Open Access | Times Cited: 13
Immunomodulatory roles of metalloproteinases in rheumatoid arthritis
Yanqin Bian, Zheng Xiang, Yaofeng Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Role and mechanism of fibroblast-activated protein-α expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis
Zihan Wang, Jinping Wang, Tianyi Lan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
PTEN: an emerging target in rheumatoid arthritis?
Zhou Pan, Xingwen Meng, Zhimin Nie, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Biology of interleukin‑37 and its role in autoimmune diseases (Review)
Huiqiong Zeng, Kaixia Zhou, Zhizhong Ye
Experimental and Therapeutic Medicine (2022) Vol. 24, Iss. 2
Open Access | Times Cited: 18
Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold
Mohamed A. Abdelgawad, Alaa M. Hayallah, Syed Nasir Abbas Bukhari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1416-1416
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top